We learn more and more every day about the bacteria, viruses, and fungi that live within us and support us. It's our own personal world: the microbiome. And researchers have identified ecologic niches with varying microbial occupants. And it seems that cities have unique microbiomes, too.
Are there methods that can be employed to ensure the commercial success of antibiotic biotech? ACSH advisor Dr. David Shlaes has his doubts.
Fish + bacteria = 25% mortality. Fish + bacteria + rocks = 5% mortality. What magic lies within the rocks? What can farm-raised fish teach us?
What would happen if we approached antibiotic resistance with the same fervor that we have for covid? Is there a reason why we should not?
Even in the time of COVID-19, antibiotic resistance remains a problem. Is it a particle or a wave? - turns out it may be neither. Zombies get all the press, but are vampires the real problem? Theory or practice? Finally, more on the science of gift-giving.
A European study found that 44% of "antibiotic-free" animal feed samples tested contained antibiotics.
The US Centers for Disease Control recently released its new report, Antibiotic Resistant Threats in the United States, 2019. ACSH Advisor Dr. David Shlaes discusses its pros and cons.
When there is little if any money to be made curing a disease, non-profits could come to the rescue.
As the rational world continues its descent into madness, the (mis)use of homeopathy seems to be spreading like wildfire. In an attempt to limit antibiotic use in animals, an E.U. group is proposing that homeopathy be used instead. By why stop there? Wouldn't homeopathic grass save a lot of acreage? Or even better, wouldn't a homeopathic cow require neither antibiotics nor grass? Spolier: Stupid alert.
Identifying the cause of an infectious disease is time-consuming and not always easy. So a company called Karius has developed a blood test that analyzes cell-free DNA to identify more than a thousand pathogens.
Promising work just published in the journal Nature Medicine offers hope when antibiotic resistance, in an extremely sick patient, renders limited treatments.